Canada markets closed

Anagenics Limited (AN1.AX)

ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
0.0080+0.0010 (+14.29%)
At close: 10:07AM AEST
Currency in AUD

Valuation Measures4

Market Cap (intraday) 3.69M
Enterprise Value 3.21M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.27
Price/Book (mrq)0.52
Enterprise Value/Revenue 0.32
Enterprise Value/EBITDA -3.98

Trading Information

Stock Price History

Beta (5Y Monthly) -1.03
52-Week Change 3-27.27%
S&P500 52-Week Change 326.24%
52 Week High 30.0280
52 Week Low 30.0060
50-Day Moving Average 30.0080
200-Day Moving Average 30.0157

Share Statistics

Avg Vol (3 month) 3573.2k
Avg Vol (10 day) 3955.79k
Shares Outstanding 5461.32M
Implied Shares Outstanding 6461.32M
Float 8201.97M
% Held by Insiders 152.60%
% Held by Institutions 112.59%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Nov 27, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -30.99%
Operating Margin (ttm)-23.11%

Management Effectiveness

Return on Assets (ttm)-12.95%
Return on Equity (ttm)-35.76%

Income Statement

Revenue (ttm)10.2M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)21.00%
Gross Profit (ttm)N/A
EBITDA -2.06M
Net Income Avi to Common (ttm)-2.58M
Diluted EPS (ttm)-0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.35M
Total Cash Per Share (mrq)0
Total Debt (mrq)871.87k
Total Debt/Equity (mrq)12.17%
Current Ratio (mrq)1.44
Book Value Per Share (mrq)0.02

Cash Flow Statement

Operating Cash Flow (ttm)-2.14M
Levered Free Cash Flow (ttm)-805.83k